| Naslov: | Navigating intraductal papillary mucinous neoplasm management through fukuoka consensus vs. european evidence-based guidelines on pancreatic cystic neoplasms : a study on two European centers |
|---|
| Avtorji: | ID Djordjević, Vladimir (Avtor)
ID Knezevic, Djordje (Avtor)
ID Trotovšek, Blaž (Avtor)
ID Tomažič, Aleš (Avtor)
ID Petrič, Miha (Avtor)
ID Hadžialjević, Benjamin (Avtor)
ID Grubor, Nikica (Avtor)
ID Djokić, Mihajlo (Avtor) |
|---|
| Datoteke: |  PDF - Predstavitvena datoteka, prenos (450,80 KB)
MD5: ABA8B4F0CBD2183BBB1A472D4E39C5CA
 URL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2072-6694/16/11/2156
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  UKC LJ - Univerzitetni klinični center Ljubljana
|
|---|
| Povzetek: | This study addresses the critical need for the accurate diagnosis and management of intraductal papillary mucinous neoplasms (IPMNs), which are pancreatic cystic neoplasm types holding a substantial potential for malignancy. It evaluates the diagnostic effectiveness of the Fukuoka consensus guidelines and the European evidence-based guidelines in detecting high-grade dysplasia/invasive carcinoma in IPMNs, utilizing a retrospective analysis of 113 patients from two European medical centers. The methods include a comparative analysis of clinical, radiological, and endoscopic ultrasonography data, alongside an assessment of guideline-driven diagnostic performance. The results demonstrate that both guidelines offer similar accuracy in identifying severe disease stages in IPMNs, with certain clinical markers-such as jaundice, solid mass presence, and an increase in CA 19-9 levels-being pivotal in predicting the need for surgical intervention. This study concludes that while both guidelines provide valuable frameworks for IPMN management, there is an inherent need for further research to refine these protocols and improve patient-specific treatment strategies. This research contributes to the ongoing discourse on optimizing diagnostic and treatment paradigms for pancreatic cystic neoplasms, aiming to enhance clinical outcomes and patient care in this challenging medical field. |
|---|
| Ključne besede: | IPMN, Serbia, Slovenia |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Leto izida: | 2024 |
|---|
| Št. strani: | str. 1-16 |
|---|
| Številčenje: | Vol. 16, no. 11 |
|---|
| PID: | 20.500.12556/DiRROS-29755  |
|---|
| UDK: | 61 |
|---|
| ISSN pri članku: | 2072-6694 |
|---|
| DOI: | 10.3390/cancers16112156 |
|---|
| COBISS.SI-ID: | 201790211 |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 15. 7. 2024;
article no.2156;
|
|---|
| Datum objave v DiRROS: | 04.06.2026 |
|---|
| Število ogledov: | 25 |
|---|
| Število prenosov: | 11 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
